Form 4: Sabra Health Care REIT Executive VP, CFO & Secretary Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Michael Lourenco Costa, Executive VP, CFO & Secretary of Sabra Health Care REIT, Inc., reports changes in beneficial ownership of company stock, including the acquisition of 3,004 shares due to dividend equivalent payments.
Summary
- Michael Lourenco Costa, an executive at Sabra Health Care REIT, Inc. (SBRA), filed a Form 4 with the SEC detailing changes in his beneficial ownership of the company's stock.
- On May 31, 2024, Costa acquired 3,004 shares of common stock due to dividend equivalent payments on previously granted stock units.
- These stock units were credited under the Issuer's 2009 Performance Incentive Plan and will vest and become payable on the same terms as the original stock units.
- The reported transaction increased Costa's direct holdings to 250,226 shares of common stock, which includes 149,017 stock units that will be paid on a one-for-one basis in shares of the Issuer's Common Stock upon settlement.
- Costa also indirectly owns 784 shares through his IRA and 207 shares through his spouse's IRA.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects routine transactions related to executive compensation. There is no indication of unusual or concerning activity.
Positives
- The acquisition of shares through dividend equivalent payments indicates the executive's continued investment in the company's success.
- The increase in direct holdings demonstrates a positive sentiment from the executive regarding the company's future performance.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors as they can provide insights into management's views on the company's prospects.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 05/31/2024 | Date of transaction: Acquisition of 3,004 shares of common stock due to dividend equivalent payments. |
| 06/04/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.